G7 leaders' call on the fight against cancer
FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC
Jérôme Salomon and Lutz Dommel: Cancer Becomes a Global Strategic Priority in Historic G7 Declaration
Yelena Janjigian Receives 2026 Fellowship Service Award at MSK
Neeraj Agarwal: AHA and ASCO Joint Statement on Defining Cardiovascular Endpoints in Oncology Trials
Delta Goodrem Inspiring Cancer Journey: Hodgkin Lymphoma, Recovery, and Eurovision Return
LAGOON Trial: 3 Critical Results From Zepzelca in Second-Line SCLC
EMBER-3 PRO Analysis Supports Quality-of-Life Profile of Imlunestrant in Advanced ER-Positive/HER2-Negative Breast Cancer
The ESMO Advanced Course on the Management of Diffuse Large B-Cell Lymphoma (DLBCL) is a specialized, multi-day educational program taking place in Singapore from June 19–20, 2026. Co-chaired by Professor Marie José Kersten and Professor Won Seog Kim, the course brings together an international faculty to explore the latest clinical advancements and biological insights into […]
